跳至主要内容
临床试验/CTRI/2023/12/060774
CTRI/2023/12/060774尚未招募4 期

A comparative study of vortioxetine and escitalopram on efficacy, tolerability and effects on metabolic parameters in the management of major depressive disorder in a tertiary care hospital. - Nil

Dr Suravi Das0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 18-45 years of male and female, diagnosed as case of major depressive disorder, not been treated for the index episode.

排除标准

  • Subjects with comorbid psychiatric disorder except for the comorbid anxiety symptoms and tobacco use, known case of diabetes or hypertension or dyslipidemia or hyperthyroidism, hypothyroidism, with medical or surgical condition that affect his or her locomotor capabilities, pregnancy and lactating female.

研究者

发起方
Dr Suravi Das

相似试验